Logo image of REC.MI

RECORDATI INDUSTRIA CHIMICA (REC.MI) Stock Fundamental Analysis

BIT:REC - Euronext Milan - IT0003828271 - Common Stock - Currency: EUR

53.55  0 (0%)

Fundamental Rating

5

Overall REC gets a fundamental rating of 5 out of 10. We evaluated REC against 52 industry peers in the Pharmaceuticals industry. While REC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. REC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year REC was profitable.
REC had a positive operating cash flow in the past year.
REC had positive earnings in each of the past 5 years.
In the past 5 years REC always reported a positive cash flow from operatings.
REC.MI Yearly Net Income VS EBIT VS OCF VS FCFREC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.07%, REC belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
REC has a Return On Equity of 22.55%. This is amongst the best in the industry. REC outperforms 84.62% of its industry peers.
The Return On Invested Capital of REC (15.08%) is better than 78.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REC is in line with the industry average of 13.62%.
The 3 year average ROIC (14.61%) for REC is below the current ROIC(15.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.07%
ROE 22.55%
ROIC 15.08%
ROA(3y)10.26%
ROA(5y)11.4%
ROE(3y)23.74%
ROE(5y)25.96%
ROIC(3y)14.61%
ROIC(5y)15.51%
REC.MI Yearly ROA, ROE, ROICREC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

REC has a Profit Margin of 18.65%. This is amongst the best in the industry. REC outperforms 84.62% of its industry peers.
REC's Profit Margin has declined in the last couple of years.
REC has a better Operating Margin (28.09%) than 86.54% of its industry peers.
In the last couple of years the Operating Margin of REC has declined.
REC has a Gross Margin (68.03%) which is comparable to the rest of the industry.
REC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.09%
PM (TTM) 18.65%
GM 68.03%
OM growth 3Y-5.88%
OM growth 5Y-3.72%
PM growth 3Y-8.63%
PM growth 5Y-4.15%
GM growth 3Y-1.7%
GM growth 5Y-0.7%
REC.MI Yearly Profit, Operating, Gross MarginsREC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

5

2. Health

2.1 Basic Checks

REC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for REC has been increased compared to 1 year ago.
REC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, REC has about the same debt to assets ratio.
REC.MI Yearly Shares OutstandingREC.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
REC.MI Yearly Total Debt VS Total AssetsREC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 4.76 indicates that REC is not in any danger for bankruptcy at the moment.
REC has a Altman-Z score of 4.76. This is amongst the best in the industry. REC outperforms 80.77% of its industry peers.
REC has a debt to FCF ratio of 3.29. This is a good value and a sign of high solvency as REC would need 3.29 years to pay back of all of its debts.
REC's Debt to FCF ratio of 3.29 is fine compared to the rest of the industry. REC outperforms 67.31% of its industry peers.
REC has a Debt/Equity ratio of 0.69. This is a neutral value indicating REC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.69, REC perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 3.29
Altman-Z 4.76
ROIC/WACC1.98
WACC7.61%
REC.MI Yearly LT Debt VS Equity VS FCFREC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.38 indicates that REC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.38, REC is in line with its industry, outperforming 53.85% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that REC may have some problems paying its short term obligations.
REC has a Quick ratio (0.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.93
REC.MI Yearly Current Assets VS Current LiabilitesREC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

REC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.74%.
Measured over the past 5 years, REC shows a small growth in Earnings Per Share. The EPS has been growing by 4.85% on average per year.
REC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.68%.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)7.74%
EPS 3Y3.69%
EPS 5Y4.85%
EPS Q2Q%46.54%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y12.85%
Revenue growth 5Y9.02%
Sales Q2Q%8.89%

3.2 Future

The Earnings Per Share is expected to grow by 13.57% on average over the next years. This is quite good.
REC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.99% yearly.
EPS Next Y13.82%
EPS Next 2Y16.99%
EPS Next 3Y14.32%
EPS Next 5Y13.57%
Revenue Next Year11.55%
Revenue Next 2Y12.21%
Revenue Next 3Y10.27%
Revenue Next 5Y7.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REC.MI Yearly Revenue VS EstimatesREC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
REC.MI Yearly EPS VS EstimatesREC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.32, the valuation of REC can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of REC is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.35, REC is valued at the same level.
The Price/Forward Earnings ratio is 18.10, which indicates a rather expensive current valuation of REC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of REC is on the same level as its industry peers.
REC is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.32
Fwd PE 18.1
REC.MI Price Earnings VS Forward Price EarningsREC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as REC.
REC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.65
EV/EBITDA 15.67
REC.MI Per share dataREC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
REC has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as REC's earnings are expected to grow with 14.32% in the coming years.
PEG (NY)1.98
PEG (5Y)5.64
EPS Next 2Y16.99%
EPS Next 3Y14.32%

6

5. Dividend

5.1 Amount

REC has a Yearly Dividend Yield of 2.30%.
Compared to an average industry Dividend Yield of 2.86, REC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, REC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

The dividend of REC is nicely growing with an annual growth rate of 6.64%!
Dividend Growth(5Y)6.64%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

REC pays out 58.40% of its income as dividend. This is a bit on the high side, but may be sustainable.
REC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.4%
EPS Next 2Y16.99%
EPS Next 3Y14.32%
REC.MI Yearly Income VS Free CF VS DividendREC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M
REC.MI Dividend Payout.REC.MI Dividend Payout, showing the Payout Ratio.REC.MI Dividend Payout.PayoutRetained Earnings

RECORDATI INDUSTRIA CHIMICA

BIT:REC (3/7/2025, 7:00:00 PM)

53.55

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-07 2025-05-07
Inst Owners27.41%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.20B
Analysts69.33
Price Target58.38 (9.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly Dividend1.2
Dividend Growth(5Y)6.64%
DP58.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.95%
PT rev (3m)4.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.84%
EPS NY rev (3m)4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 27.32
Fwd PE 18.1
P/S 4.94
P/FCF 23.65
P/OCF 21.11
P/B 5.97
P/tB N/A
EV/EBITDA 15.67
EPS(TTM)1.96
EY3.66%
EPS(NY)2.96
Fwd EY5.52%
FCF(TTM)2.26
FCFY4.23%
OCF(TTM)2.54
OCFY4.74%
SpS10.85
BVpS8.97
TBVpS-3.64
PEG (NY)1.98
PEG (5Y)5.64
Profitability
Industry RankSector Rank
ROA 10.07%
ROE 22.55%
ROCE 19.33%
ROIC 15.08%
ROICexc 16.23%
ROICexgc 111.87%
OM 28.09%
PM (TTM) 18.65%
GM 68.03%
FCFM 20.87%
ROA(3y)10.26%
ROA(5y)11.4%
ROE(3y)23.74%
ROE(5y)25.96%
ROIC(3y)14.61%
ROIC(5y)15.51%
ROICexc(3y)16.09%
ROICexc(5y)17.03%
ROICexgc(3y)129.61%
ROICexgc(5y)128.14%
ROCE(3y)18.95%
ROCE(5y)20.01%
ROICexcg growth 3Y-2.95%
ROICexcg growth 5Y-3.6%
ROICexc growth 3Y-8.7%
ROICexc growth 5Y-9.25%
OM growth 3Y-5.88%
OM growth 5Y-3.72%
PM growth 3Y-8.63%
PM growth 5Y-4.15%
GM growth 3Y-1.7%
GM growth 5Y-0.7%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 3.29
Debt/EBITDA 1.61
Cap/Depr 35.41%
Cap/Sales 2.5%
Interest Coverage 7.56
Cash Conversion 66.49%
Profit Quality 111.93%
Current Ratio 1.38
Quick Ratio 0.93
Altman-Z 4.76
F-Score8
WACC7.61%
ROIC/WACC1.98
Cap/Depr(3y)144.92%
Cap/Depr(5y)228.37%
Cap/Sales(3y)9.71%
Cap/Sales(5y)13.63%
Profit Quality(3y)82.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.74%
EPS 3Y3.69%
EPS 5Y4.85%
EPS Q2Q%46.54%
EPS Next Y13.82%
EPS Next 2Y16.99%
EPS Next 3Y14.32%
EPS Next 5Y13.57%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y12.85%
Revenue growth 5Y9.02%
Sales Q2Q%8.89%
Revenue Next Year11.55%
Revenue Next 2Y12.21%
Revenue Next 3Y10.27%
Revenue Next 5Y7.99%
EBIT growth 1Y16.17%
EBIT growth 3Y6.22%
EBIT growth 5Y4.97%
EBIT Next Year47.64%
EBIT Next 3Y20.43%
EBIT Next 5Y14.86%
FCF growth 1Y21.16%
FCF growth 3Y-27.87%
FCF growth 5Y-21.32%
OCF growth 1Y9.32%
OCF growth 3Y6.34%
OCF growth 5Y6.28%